Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;34(8):107607.
doi: 10.1016/j.jdiacomp.2020.107607. Epub 2020 Apr 27.

Time in suboptimal glycemic control over 10 years for patients newly diagnosed with type 2 diabetes

Affiliations

Time in suboptimal glycemic control over 10 years for patients newly diagnosed with type 2 diabetes

Jaejin An et al. J Diabetes Complications. 2020 Aug.

Abstract

Objective: To estimate time in suboptimal glycemic control among patients with incident type 2 diabetes (T2D) over 10 years.

Methods: We calculated percent of time in suboptimal glycemic control using three A1C thresholds (8%, 7.5%, 7%) following T2D diagnosis. Stratified analyses were conducted based on age and A1C levels at T2D diagnosis.

Results: We identified 28,315 patients with incident T2D. Percent of time in suboptimal glycemic control increased with T2D duration. Mean percent time in suboptimal A1C control in the first 2 years following diagnosis was 30%, 34% and 40% for the 8%, 7.5%, and 7% thresholds, respectively. In the 6-10 years following T2D diagnosis, the percent time in suboptimal A1C control increased to 39%, 48% and 61%, for the 8%, 7.5%, and 7% thresholds, respectively. Time in suboptimal glycemic control was longer among younger patients aged 20-44 versus ≥65 years and those with higher A1C (>8%) versus lower A1C (<7%) at diagnosis.

Conclusions: Over 10 years following diagnosis, T2D patients spent one-third to over one-half of their time in suboptimal glycemic control. Reducing time spent above desired A1C targets could lower risk of microvascular and macrovascular complications.

Keywords: Glycemic control; Hemoglobin A1c; Type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: J.A., K.R. are employees of Kaiser Permanente Southern California and G.A.N. is employee of Kaiser Permanente Northwest who received funding through their institutions from Merck & Co., Inc. for the conduct of this study. T.W., S.R. are employees of Merck & Co., Inc.

Publication types

Substances

LinkOut - more resources